Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-06-04

Clinical Trial Update: Study of Nitazoxanide (NTZ) for Helicobacter Pylori in Children [Phase 3]

View source ↗

Summary

Phase 3 clinical trial investigating nitazoxanide for Helicobacter pylori infection in children. Recruitment is ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Nitazoxanide (nitazoxanide)

Snippet

Sponsor: Tanta University | Conditions: Helicobacter Pylori Infection | Phase 3 | Status: RECRUITING